Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 13651-13700 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06735144
Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors
PHASE1/PHASE2Recruiting
200 participants
Started: Dec 23, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06705387
Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE
PHASE2Recruiting
72 participants
Started: Dec 23, 2024 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT06761027
mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer
PHASE1/PHASE2Recruiting
29 participants
Started: Dec 23, 2024 · Completed: May 31, 2027
2 conditions1 sponsor4 locations
NCT06719791
Sirolomus Adjuvant Treatment of Focal Refractory Epilepsy (SATFRE)
EARLY_PHASE1Recruiting
15 participants
Started: Dec 23, 2024 · Completed: Dec 1, 2028
1 condition2 sponsors1 location
NCT06742697
Flexibility, Resistance, Aerobic, Movement Execution Training in Adults With Hereditary Spastic Paraplegia
NARecruiting
20 participants
Started: Dec 23, 2024 · Completed: Apr 30, 2027
1 condition1 sponsor2 locations
NCT06805695
Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)
N/ARecruiting
13 participants
Started: Dec 23, 2024 · Completed: Jul 31, 2041
3 conditions1 sponsor1 location
NCT06745869
Effects of Aerobic and Diaphragmatic Exercises on Choir Singers
NARecruiting
42 participants
Started: Dec 23, 2024 · Completed: Jul 1, 2025
2 conditions1 sponsor1 location
NCT06727448
Translation and Validation of the French Version of the Sleep Regularity Questionnaire: a New Tool to Address the the Challenge of Sleep Health
N/ARecruiting
50 participants
Started: Dec 23, 2024 · Completed: Dec 23, 2025
2 conditions1 sponsor1 location
NCT06771544
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
PHASE2Recruiting
14 participants
Started: Dec 23, 2024 · Completed: Dec 31, 2028
4 conditions1 sponsor1 location
NCT06772740
Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma
NARecruiting
600 participants
Started: Dec 23, 2024 · Completed: Mar 31, 2029
2 conditions1 sponsor1 location
NCT06280092
Allogenic Adipose-derived Mesenchymal Stem Cells(AMSCs) for Epilepsy During Deep Brain Stimulation(DBS) Surgery
EARLY_PHASE1Recruiting
5 participants
Started: Dec 23, 2024 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06658041
Collaborative Stepped-care Intervention for Adults With Subthreshold Depressive Symptoms in the Primary Care Setting
NARecruiting
352 participants
Started: Dec 23, 2024 · Completed: Jun 30, 2027
1 condition20 sponsors1 location
NCT06747156
A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases
EARLY_PHASE1Recruiting
26 participants
Started: Dec 23, 2024 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT06752668
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
PHASE2Recruiting
96 participants
Started: Dec 23, 2024 · Completed: Dec 31, 2025
3 conditions1 sponsor28 locations
NCT06795152
Rare Glycogen Storage Diseases Natural History Study
N/ARecruiting
200 participants
Started: Dec 23, 2024 · Completed: Dec 31, 2034
15 conditions1 sponsor1 location
NCT06830356
Somatostatin Receptor PET Imaging to Guide Radiotherapy Dose Escalation in High Risk Meningiomas.
NARecruiting
53 participants
Started: Dec 23, 2024 · Completed: Dec 23, 2037
1 condition1 sponsor1 location
NCT06684496
A Study of High-intensity Strength Training and Thoracic Aorta Dilatation
N/ARecruiting
45 participants
Started: Dec 23, 2024 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT06660355
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
PHASE2Recruiting
120 participants
Started: Dec 23, 2024 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT06674356
The Effects of Chin Tuck Against Resistance Exercise on Acute Stroke Patients With Dysphagia
NARecruiting
74 participants
Started: Dec 22, 2024 · Completed: Oct 31, 2027
2 conditions1 sponsor1 location
NCT07016126
D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC
PHASE3Recruiting
70 participants
Started: Dec 22, 2024 · Completed: Dec 22, 2027
1 condition1 sponsor1 location
NCT06701331
Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic Dermatitis
PHASE3Recruiting
98 participants
Started: Dec 22, 2024 · Completed: Jan 31, 2027
1 condition1 sponsor25 locations
NCT06939582
Hydroxychloroquine Sulfate Tablets for Radiation-induced Oral Mucositis
PHASE1/PHASE2Recruiting
158 participants
Started: Dec 22, 2024 · Completed: Jun 20, 2025
1 condition1 sponsor1 location
NCT06865638
Efficacy and Safety of Colorectal Anastomotic Leak Testing
NARecruiting
264 participants
Started: Dec 22, 2024 · Completed: Apr 1, 2026
5 conditions1 sponsor1 location
NCT06866496
Optimized Remission in Alcohol-related Liver Cirrhosis
NARecruiting
350 participants
Started: Dec 22, 2024 · Completed: Dec 31, 2034
2 conditions1 sponsor1 location
NCT06753773
Red Light Therapy: Short-term Choroidal and Retinal Changes
NARecruiting
60 participants
Started: Dec 22, 2024 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06752577
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
N/ARecruiting
50 participants
Started: Dec 22, 2024 · Completed: Dec 31, 2031
1 condition2 sponsors1 location
NCT06635902
Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
PHASE2Recruiting
99 participants
Started: Dec 22, 2024 · Completed: Mar 31, 2029
2 conditions2 sponsors1 location
NCT06852937
Using da Vinci SP System for Patients With Cholelithiasis and Choledocholithiasis
NARecruiting
25 participants
Started: Dec 21, 2024 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT06745648
Carotid Sinus Massage in Trendelenburg Position for Headache Relief
NARecruiting
18 participants
Started: Dec 21, 2024 · Completed: Dec 30, 2025
2 conditions2 sponsors1 location
NCT06657911
Size Up Bicuspid with the LIra MEthod: the SUBLIME Study
N/ARecruiting
250 participants
Started: Dec 21, 2024 · Completed: Apr 30, 2026
1 condition1 sponsor5 locations
NCT06762821
A 24-month Outcomes of Single- Vs Multiple-visit Revascularization
NARecruiting
86 participants
Started: Dec 21, 2024 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT06782243
Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome
NARecruiting
190 participants
Started: Dec 20, 2024 · Completed: Aug 25, 2025
1 condition2 sponsors1 location
NCT06652607
PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer
N/ARecruiting
152 participants
Started: Dec 20, 2024 · Completed: Apr 30, 2028
3 conditions1 sponsor1 location
NCT06245603
A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer
NARecruiting
200 participants
Started: Dec 20, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors9 locations
NCT06755190
Ophthalmic Multimodal AI-Assisted Medical Decision-Making
N/ARecruiting
5,000,000 participants
Started: Dec 20, 2024 · Completed: May 31, 2025
1 condition1 sponsor5 locations
NCT06607341
Community Engagement Alliance Against Disparities
NARecruiting
664 participants
Started: Dec 20, 2024 · Completed: Sep 30, 2027
4 conditions7 sponsors2 locations
NCT06744413
Prehabilitation to Improve Heart Rate Variability (PRIME)
NARecruiting
600 participants
Started: Dec 20, 2024 · Completed: Nov 30, 2026
1 condition4 sponsors4 locations
NCT06780410
A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid
PHASE3Recruiting
240 participants
Started: Dec 20, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06737822
Upfront Surgery Vs Induction Chemotherapy Followed By Surgery In Oral Cancers:
PHASE3Recruiting
346 participants
Started: Dec 20, 2024 · Completed: Oct 31, 2029
2 conditions7 sponsors7 locations
NCT06828861
ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial
PHASE3Recruiting
90 participants
Started: Dec 20, 2024 · Completed: Apr 30, 2026
2 conditions1 sponsor44 locations
NCT05401032
Proof-of-concept Study to Evaluate the Safety and Efficacy of Tryptophan in Patients with BPH.
PHASE2Recruiting
70 participants
Started: Dec 20, 2024 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06698536
OBPM_COYOTE2024 Physiological Data Recording With the Calibration-free Optical Aktiia G2C Device at Fingertip and Wrist, Alongside the Aktiia Oscillometric Cuff
NARecruiting
255 participants
Started: Dec 20, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06643000
Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis
NARecruiting
60 participants
Started: Dec 20, 2024 · Completed: May 30, 2025
3 conditions1 sponsor2 locations
NCT06735131
The Optimal Radioimmunotherapy Combinations for Advanced TNBC
PHASE2Recruiting
60 participants
Started: Dec 20, 2024 · Completed: Jan 31, 2027
1 condition3 sponsors1 location
NCT06848374
Dose Efficacy in Adhesive Capsulitis
PHASE3Recruiting
40 participants
Started: Dec 20, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06740409
Accuracy and External Validation of mREMS in Road Traffic Injuries
N/ARecruiting
180 participants
Started: Dec 20, 2024 · Completed: May 15, 2025
1 condition1 sponsor1 location
NCT07015502
Self-Dehumanization and Hesitation to Report Domestic Violence
N/ARecruiting
84 participants
Started: Dec 20, 2024 · Completed: Dec 19, 2025
1 condition1 sponsor2 locations
NCT03593317
Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
PHASE2Recruiting
120 participants
Started: Dec 20, 2024 · Completed: Dec 31, 2029
1 condition1 sponsor13 locations
NCT06463418
Exoskeleton Training for Spinal Cord Injury Neuropathic Pain (ExSCIP)
NARecruiting
40 participants
Started: Dec 20, 2024 · Completed: Nov 30, 2026
1 condition3 sponsors1 location
NCT06525571
Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
PHASE3Recruiting
200 participants
Started: Dec 20, 2024 · Completed: Jan 4, 2028
1 condition2 sponsors2 locations